Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00772161Phase 2Completed
A Phase 2 trial of methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by University Hospital Freiburg. Started Oct 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00772161.